compound
SS-31 (10mg Vial) Questions Answered
SS‑31 (elamipretide) is a mitochondria‑targeted tetrapeptide that selectively binds cardiolipin in the inner mitochondrial membrane [1] , stabilizing electron transport chain complexes and reducing reactive oxygen species production while enhancing ATP synt...
SS-31 (10mg Vial)
Week Daily Dose (mg) Units (per injection) (mL) Weeks 1–2 5 mg (5000 mcg) 50 units (0.50 mL) Weeks 3–8 10 mg (10,000 mcg) 100 units (1.0 mL) Frequency: Inject once daily subcutaneously at a consistent time.
SS‑31 (elamipretide) is a mitochondria‑targeted tetrapeptide that selectively binds cardiolipin in the inner mitochondrial membrane [1] , stabilizing electron transport chain complexes and reducing reactive oxygen species production while enhancing ATP synt...
Week Daily Dose (mg) Units (per injection) (mL) Weeks 1–2 5 mg (5000 mcg) 50 units (0.50 mL) Weeks 3–8 10 mg (10,000 mcg) 100 units (1.0 mL) Frequency: Inject once daily subcutaneously at a consistent time.
Plan based on an 8–12 week daily protocol with gradual titration. Peptide Vials (SS‑31, 10 mg each): 8 weeks (Standard: 5–10 mg/day) ≈ 50 vials 12 weeks (Standard maintenance at 10 mg/day) ≈ 77 vials 12 weeks (Advanced: escalating to 15 mg/day) ≈ 105 vials...
Practical considerations for consistency, safety, and tolerability. Use new sterile insulin syringes for each injection; dispose in a sharps container immediately after use.